Group by:
Item Type |
DateNumber of items: 12.
Journal article
Liu, Fangteng; Bouznad, Nassim; Kaller, Markus; Shi, Xiaolong; König, Janine; Jaeckel, Stephanie und Hermeking, Heiko
(2022):
Csf1r mediates enhancement of intestinal tumorigenesis caused by inactivation of Mir34a.
In: International Journal of Biological Sciences, Vol. 18, No. 14: pp. 5415-5437
[PDF, 6MB]
Wirth, Anna-Katharina; Wange, Lucas; Vosberg, Sebastian; Henrich, Kai-Oliver; Rausch, Christian; Oezdemir, Erbey; Zeller, Christina M.; Richter, Daniel; Feuchtinger, Tobias; Kaller, Markus; Hermeking, Heiko; Greif, Philipp A.; Senft, Daniela; Jurinovic, Vindi; Bahrami, Ehsan; Jayavelu, Ashok Kumar; Westermann, Frank; Mann, Matthias; Enard, Wolfgang; Herold, Tobias und Jeremias, Irmela
(2022):
In vivo PDX CRISPR/Cas9 screens reveal mutual therapeutic targets to overcome heterogeneous acquired chemo-resistance.
In: Leukemia, Vol. 36: pp. 2863-2874
Lamprecht, Sebastian; Kaller, Markus; Schmidt, Eva Marina; Blaj, Cristina; Schiergens, Tobias S.; Engel, Jutta; Jung, Andreas; Hermeking, Heiko; Grünewald, Thomas G. P.; Kirchner, Thomas und Horst, David
(2018):
PBX3 Is Part of an EMT Regulatory Network and Indicates Poor Outcome in Colorectal Cancer.
In: Clinical cancer research, Vol. 24, No. 8: pp. 1974-1986
Jaeckel, Stephanie; Kaller, Markus; Jackstadt, Rene; Götz, Ursula; Müller, Susanna; Boos, Sophie; Horst, David; Jung, Peter und Hermeking, Heiko
(2018):
Ap4 is rate limiting for intestinal tumor formation by controlling the homeostasis of intestinal stem cells.
In: Nature Communications, Vol. 9, 3573
[PDF, 3MB]
Book Section
Kaller, Markus; Hünten, Sabine; Siemens, Helge und Hermeking, Heiko
(2022):
Analysis of the p53/microRNA Network in Cancer.
In: Schmitz, Ulf; Wolkenhauer, Olaf und Vera-González, Julio (eds.) :
Systems Biology of MicroRNAs in Cancer. Advances in Experimental Medicine and Biology, Vol. 1385. Cham: Springer. pp. 187-228
This list was generated on Sun Oct 13 04:01:10 2024 CEST.